RAMSAY HLTH.CARE ADR/025 (F:RMY0) — Stock Price
RAMSAY HLTH.CARE ADR/025 (F:RMY0) is currently trading at €5.65 EUR, down 2.59% today. Over the past 52 weeks, shares have ranged between €4.04 and €6.50. This page tracks RAMSAY HLTH.CARE ADR/025's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To understand the scale of the balance sheet behind this price, see RMY0 total assets.
RAMSAY HLTH.CARE ADR/025 (RMY0) Stock Price Chart — Daily History & Trading Volume
The chart below tracks RAMSAY HLTH.CARE ADR/025's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
RAMSAY HLTH.CARE ADR/025 Income Statement — Revenue, Profit & Earnings by Year
RAMSAY HLTH.CARE ADR/025's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €17.67 Billion | €16.56 Billion | €14.86 Billion | €13.08 Billion |
| Cost of Revenue | €4.00 Billion | €3.71 Billion | €3.35 Billion | €3.11 Billion |
| Gross Profit | €13.67 Billion | €12.85 Billion | €11.52 Billion | €9.97 Billion |
| Research & Development | — | — | — | — |
| SG&A | €11.04 Billion | €10.32 Billion | €9.43 Billion | €8.31 Billion |
| Total Operating Expenses | — | — | — | — |
| Operating Income | €870.50 Million | €833.20 Million | €554.20 Million | €230.60 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €335.20 Million | €339.50 Million | €261.20 Million | €146.80 Million |
| Income Before Tax | €101.80 Million | €384.60 Million | €527.10 Million | €538.50 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €24.00 Million | €888.70 Million | €298.10 Million | €274.00 Million |
RAMSAY HLTH.CARE ADR/025 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes RAMSAY HLTH.CARE ADR/025's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €22.48 Billion | €20.89 Billion | €21.03 Billion | €19.47 Billion |
| Total Current Assets | €4.04 Billion | €3.87 Billion | €3.90 Billion | €3.29 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | €2.70 Billion | €2.67 Billion | €2.40 Billion | €2.40 Billion |
| Inventory | €404.40 Million | €379.40 Million | €388.60 Million | €376.80 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €6.01 Billion | €5.74 Billion | €5.76 Billion | €5.36 Billion |
| Total Liabilities | €16.77 Billion | €15.37 Billion | €16.21 Billion | €14.95 Billion |
| Total Current Liabilities | €4.47 Billion | €4.18 Billion | €3.81 Billion | €3.73 Billion |
| Long-term Debt | €5.46 Billion | €4.95 Billion | €5.86 Billion | €5.17 Billion |
| Net Debt | €4.75 Billion | €4.42 Billion | €5.28 Billion | €4.90 Billion |
| Total Stockholder Equity | €5.02 Billion | €4.90 Billion | €4.15 Billion | €3.93 Billion |
| Retained Earnings | €2.33 Billion | €2.50 Billion | €1.79 Billion | €1.71 Billion |
RAMSAY HLTH.CARE ADR/025 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how RAMSAY HLTH.CARE ADR/025 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year |
|---|
| Operating Cash Flow |
| Capital Expenditures |
| Free Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Dividends Paid |
| Stock-Based Compensation |
| Depreciation |
| Change in Cash |
RAMSAY HLTH.CARE ADR/025 Earnings History — EPS Actual vs. Analyst Estimates
Track RAMSAY HLTH.CARE ADR/025's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 25, 2026 | — | — | — |
| Nov 26, 2025 | — | — | — |
| Aug 28, 2025 | — | — | — |
| Feb 26, 2025 | — | — | — |
| Nov 26, 2024 | — | — | — |